About Embecta Corp. 
Embecta Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 71 Schemes (50.58%)
Foreign Institutions
Held by 134 Foreign Institutions (9.01%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
261 Million
(Quarterly Results - Dec 2025)
Net Profit:
44 Million
Pharmaceuticals & Biotechnology
USD 522 Million (Micro Cap)
3.00
NA
6.68%
-1.91
-999,999.00%
-0.85






